Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,732.50
17.85 (0.66%)
BSENSE

Nov 20

BSE+NSE Vol: 95.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
1,183.57
938.44
995.30
1,041.26
979.94
805.17
974.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,183.57
938.44
995.30
1,041.26
979.94
805.17
974.37
Raw Material Cost
128.92
72.95
113.06
79.90
115.13
128.06
115.23
Purchase of Finished goods
279.04
378.62
228.40
217.27
232.72
232.06
291.40
(Increase) / Decrease In Stocks
36.52
-123.63
2.54
66.65
7.68
-72.41
-54.69
Employee Cost
170.19
159.04
164.75
151.88
138.05
152.57
152.97
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
166.83
155.96
135.62
154.22
150.63
113.69
136.27
Total Expenditure (Excl Depreciation)
781.50
642.94
644.37
669.92
644.21
553.97
641.18
Operating Profit (PBDIT) excl Other Income
402.07
295.50
350.93
371.34
335.73
251.20
333.19
Other Income
72.78
43.76
35.95
32.12
33.57
43.72
40.68
Operating Profit (PBDIT)
474.85
339.26
386.88
403.46
369.30
294.92
373.87
Interest
0.49
0.97
0.61
1.19
0.51
0.42
0.58
Exceptional Items
0.00
0.00
0.00
17.98
2.64
0.00
0.00
Gross Profit (PBDT)
474.36
338.29
386.27
420.25
371.43
294.50
373.29
Depreciation
15.02
15.84
13.17
20.32
17.43
15.52
14.72
Profit Before Tax
459.34
322.45
373.10
399.93
354.00
278.98
358.57
Tax
123.46
85.27
95.24
104.31
96.51
73.97
95.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
335.88
237.18
277.86
295.62
257.49
205.01
262.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
335.88
237.18
277.86
295.62
257.49
205.01
262.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
335.88
237.18
277.86
295.62
257.49
205.01
262.87
Equity Capital
169.41
169.41
169.41
169.41
169.41
169.41
169.41
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
19.83
14.0
16.4
17.45
15.2
12.1
15.52
Diluted Earnings per share
19.83
14.0
16.4
17.45
15.02
12.1
15.52
Operating Profit Margin (Excl OI)
33.97%
31.49%
35.26%
35.66%
34.26%
31.2%
34.2%
Gross Profit Margin
40.08%
36.05%
38.81%
40.36%
37.9%
36.58%
38.31%
PAT Margin
28.38%
25.27%
27.92%
28.39%
26.28%
25.46%
26.98%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 26.12% vs -5.71% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 41.61% vs -14.64% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 36.06% vs -15.80% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -49.48% vs 59.02% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Glaxosmi. Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,183.57
2,909.94
-1,726.37
-59.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,183.57
2,909.94
-1,726.37
-59.33%
Raw Material Cost
128.92
746.67
-617.75
-82.73%
Purchase of Finished goods
279.04
152.55
126.49
82.92%
(Increase) / Decrease In Stocks
36.52
-85.26
121.78
142.83%
Employee Cost
170.19
617.43
-447.24
-72.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
166.83
805.07
-638.24
-79.28%
Total Expenditure (Excl Depreciation)
781.50
2,236.46
-1,454.96
-65.06%
Operating Profit (PBDIT) excl Other Income
402.07
673.48
-271.41
-40.30%
Other Income
72.78
25.03
47.75
190.77%
Operating Profit (PBDIT)
474.85
698.51
-223.66
-32.02%
Interest
0.49
12.57
-12.08
-96.10%
Exceptional Items
0.00
-24.26
24.26
100.00%
Gross Profit (PBDT)
474.36
661.68
-187.32
-28.31%
Depreciation
15.02
114.51
-99.49
-86.88%
Profit Before Tax
459.34
547.17
-87.83
-16.05%
Tax
123.46
155.63
-32.17
-20.67%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
335.88
391.54
-55.66
-14.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
335.88
391.54
-55.66
-14.22%
Share in Profit of Associates
0.00
-2.22
2.22
100.00%
Minority Interest
0.00
14.19
-14.19
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
335.88
375.13
-39.25
-10.46%
Equity Capital
169.41
25.37
144.04
567.76%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
19.83
14.79
5.04
34.08%
Diluted Earnings per share
19.83
14.79
5.04
34.08%
Operating Profit Margin (Excl OI)
33.97%
23.14%
0.00
10.83%
Gross Profit Margin
40.08%
22.74%
0.00
17.34%
PAT Margin
28.38%
13.46%
0.00
14.92%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,183.57 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 26.12% vs -5.71% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 20.78% vs -3.05% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 335.88 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 41.61% vs -14.64% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 30.44% vs 1.98% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 402.07 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 36.06% vs -15.80% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 19.76% vs 4.36% in Sep 2025

Quarterly - Interest
Interest 0.49 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -49.48% vs 59.02% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -3.92% vs 88.89% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.97%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025